GovChime
Notice ID: f8f6f3a729264709a1d84a6c9b022e22Solicitation

Multi species Hematology System

Archived on September 21, 2022. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
5:00 PM UTC−04:00
Posted
August 24, 2022
Notice type
Solicitation
NAICS
334516: Analytical Laboratory Instrument Manufacturing
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH NHLBI
Place of performance
Bethesda, MD, 20892
Last updated
Dec 4, 2025

Identifiers

Solicitation number
NHLBI-22-016942
Notice ID
f8f6f3a729264709a1d84a6c9b022e22

Description

Example item list from requested machine below. QTY. 1 Multi species Analyzer QTY. 1 HFRO Key (add on) optional (installed) QTY. 1 HVDMS Interface Software for Excel Spreadsheet on host Computer (included) QTY. 1 Laser Jet or Equivalent Printer QTY. 1 Start-up Reagent Kit QTY. 1 Alpha/Numeric ID keyboard QTY. 1 Serial interface port and interface specifications QTY. 150 specimen data storage QTY. 1 Full-Year Warranty on all Parts and Labor QTY. 1 Virtual installation Included Shipping & Handling Statement of Need/Purpose and Objectives The Laboratory of Vascular Inflammation and Thrombosis (LVTI) within the Translational Vascular Medicine Branch (TVMB) is currently in need of a blood cell analyzer for determining differential blood counts in non-coagulated whole blood from patient and rodent blood samples. The LVTI regularly performs experiments on rodent models to look at the contribution of various genes to thrombosis and inflammation and explore strategies to mitigate any adverse effects. During these studies in animal models, the differential blood counts in systemic circulation might get altered. Determining the differential blood count is therefore important to understand the role of gene(s) being investigated in maintaining homeostasis. LVTI also systematically evaluates blood cells in patients blood samples for evidence of activation that may contribute to thrombosis and inflammation. Determining blood cell counts in patient samples helps us to determine the volume of patient blood sample needed for an ex vivo experiment. Measuring the differential blood counts is thus essential in determining the physiological impact of genes/proteins in rodent experiments and to effectively accomplish the goals of an ex vivo experiment performed with limited patient samples. The objective of this purchase is to procure a blood cell analyzer in support of these studies that are aligned with the goals of the LVTI and mission critical for the NHLBI and NIH. Product Specifications/Features/Salient Characteristics Key characteristics essential for the blood cell analyzer system are as follows: 1. Must be able to determine the differential blood count for human, mouse and rat samples. 2. Must have dedicated pre-programmed species keys for human, mouse and rat samples. 3. Must be fast enough to process up to 25 samples per hour. 4. Must have an extended operating range to ensure accuracy for samples with very high cell counts.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:NHLBI-22-016942
  1. Solicitation

Award typically follows within 30–90 days after the response deadline. (estimate)

  1. 2×
    SolicitationCurrentAug 23, 2022

    Multi species Hematology System

    Notice f8f6f3a729264709a1d84a6c9b022e22 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

NHLBI-22-016942

Archive Date

Sep 21, 2022

Office Address

BETHESDA, MD, 20892